AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18443191 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril (2 mg/day)
Number of subjects: 816
Study 18443191 — intervention group
Group type: COMPARATOR
Intervention: Non-ACE inhibitor therapy
Number of subjects: 816
Study 17343258 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared radiation of a tiled stove (3 hours, three times a week for 3 weeks)
Number of subjects: 45
Study 17343258 — intervention group
Group type: COMPARATOR
Intervention: Control period (2 weeks without treatment)
Number of subjects: 45
Study 17343258 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared radiation of a tiled stove
Number of subjects: 45
Study 14665584 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate ingestion (1 litre of solution containing 0.5 g of sodium citrate/kg body mass two hours before the run)
Number of subjects: 17
Study 14665584 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate ingestion
Number of subjects: 17
Study 14665584 — intervention group
Group type: COMPARATOR
Intervention: Placebo (flavoured mineral water)
Number of subjects: 17
Study 14665584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11789260 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus‐Polygonum Anti‐Fibrosis Decoction (APAFD) for 48 weeks
Number of subjects: 92
Study 11789260 — intervention group
Group type: COMPARATOR
Intervention: Jinshuibao capsule (JSBC) for 48 weeks
Number of subjects: 92
Study 8977503 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical levocabastine (0.05%)
Number of subjects: 24
Study 8977503 — intervention group
Group type: COMPARATOR
Intervention: Nedocromil (2%)
Number of subjects: 24
Study 1335460 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 0
Study 1335460 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 0
Study 1335460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.19 mg/kg)
Number of subjects: 6
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (0.19 mg/kg)
Number of subjects: 6
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol (0.64 mg/kg)
Number of subjects: 6
Study 6202971 — intervention group
Group type: COMPARATOR
Intervention: Control (no beta-blocker)
Number of subjects: 6
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol treatment
Number of subjects: 6
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol treatment
Number of subjects: 6
Study 6202971 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol treatment
Number of subjects: 6
Study 29313286 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily single inhaler triple therapy (fluticasone furoate/umeclidinium/vilanterol) 100 µg/62.5 µg/25 µg
Number of subjects: 0
Study 29313286 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily inhaled corticosteroid/long-acting β2-agonist therapy (budesonide/formoterol) 400 µg/12 µg
Number of subjects: 0
Study 27744268 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized assessments of mental and motor development at ages 6, 12, and 24 months; intelligence, adaptive functioning, and motor skills at 10.7 years
Number of subjects: 123
Study 27744268 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized assessments at 10.7 years
Number of subjects: 123
Study 27744268 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographics, comorbidity, and developmental outcomes
Number of subjects: 123
Study 27744268 — intervention group
Group type: EXPERIMENTAL
Intervention: Early life characteristics
Number of subjects: 123
Study 25665513 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure Exposure (n=14)
Number of subjects: 29
Study 25665513 — intervention group
Group type: COMPARATOR
Intervention: Guided Exposure (n=15)
Number of subjects: 29
Study 23089047 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BZK) gel
Number of subjects: 240
Study 23089047 — intervention group
Group type: COMPARATOR
Intervention: Nonoxynol-9 (N-9) gel
Number of subjects: 240
Study 21906507 — intervention group
Group type: EXPERIMENTAL
Intervention: Neighborhood context, home and family management practices, deviant peer affiliations, beliefs favorable to use
Number of subjects: 4027
Study 21906507 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive efforts focusing on neighborhood deprivation, exposure to alcohol advertisements, and home risks and protective factors
Number of subjects: 4027
Study 18713505 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-treatment chest radiograph (EOT CXR) showing persistent cavity
Number of subjects: 1004
Study 18713505 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-treatment chest radiograph (EOT CXR) showing resolved cavity
Number of subjects: 1004
Study 18713505 — intervention group
Group type: EXPERIMENTAL
Intervention: No cavity on baseline or 2-month CXR
Number of subjects: 1004
Study 18713505 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent cavity on EOT CXR
Number of subjects: 1004
Study 18713505 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolved cavity by EOT CXR
Number of subjects: 1004
Study 16540829 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training (HI)
Number of subjects: 21
Study 16540829 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (MI)
Number of subjects: 21
Study 16540829 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 21
Study 15007396 — intervention group
Group type: COMPARATOR
Intervention: Standard protein diet (SP; 15% protein, 55% carbohydrate)
Number of subjects: 58
Study 15007396 — intervention group
Group type: COMPARATOR
Intervention: High-protein diet (HP; 30% protein, 40% carbohydrate)
Number of subjects: 58
Study 11345282 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF-DPI) 400 microg twice daily
Number of subjects: 733
Study 11345282 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF-DPI) 200 microg twice daily
Number of subjects: 733
Study 11345282 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) Diskhaler 250 microg twice daily
Number of subjects: 733
Study 11345282 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF-DPI) 100 microg twice daily
Number of subjects: 733
Study 11345282 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) Diskhaler
Number of subjects: 733
Study 9236420 — intervention group
Group type: EXPERIMENTAL
Intervention: Xemilofiban 35 mg orally before and 20 to 25 mg TID for 30 days after angioplasty
Number of subjects: 30
Study 9236420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9236420 — intervention group
Group type: EXPERIMENTAL
Intervention: Xemilofiban
Number of subjects: 30
Study 8198892 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnarail system (primary system)
Number of subjects: 50
Study 8198892 — intervention group
Group type: EXPERIMENTAL
Intervention: Omniflex system (primary system)
Number of subjects: 50
Study 8198892 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 50
Study 3145958 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with adrenaline 1:80,000
Number of subjects: 5
Study 3145958 — intervention group
Group type: COMPARATOR
Intervention: Control (Lidocaine without adrenaline)
Number of subjects: 5
Study 28905123 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating-rotating toothbrush with instruction (OR-I)
Number of subjects: 150
Study 28905123 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic-active toothbrush with instruction (SA-I)
Number of subjects: 150
Study 28905123 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush with instruction (MTB-I)
Number of subjects: 150
Study 28905123 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic-active toothbrush without instruction (SA-NI)
Number of subjects: 150
Study 28905123 — intervention group
Group type: COMPARATOR
Intervention: All toothbrush systems
Number of subjects: 150
Study 28905123 — intervention group
Group type: EXPERIMENTAL
Intervention: All toothbrush systems with instruction
Number of subjects: 150
Study 27389186 — intervention group
Group type: EXPERIMENTAL
Intervention: Bullying and FKBP5 haplotype interaction
Number of subjects: 206
Study 27389186 — intervention group
Group type: EXPERIMENTAL
Intervention: Social stress appraisal (being alone due to social rejection)
Number of subjects: 206
Study 25548107 — intervention group
Group type: EXPERIMENTAL
Intervention: Δ(9)‐tetrahydrocannabinol
Number of subjects: 16
Study 25548107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22753906 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-directed computerized decision aid (DA) with usual care
Number of subjects: 74
Study 22753906 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (control)
Number of subjects: 74
Study 20446632 — intervention group
Group type: EXPERIMENTAL
Intervention: Literature review and audit
Number of subjects: 0
Study 18724149 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-site phacotrabeculectomy
Number of subjects: 113
Study 18724149 — intervention group
Group type: COMPARATOR
Intervention: 1-site phacotrabeculectomy
Number of subjects: 113
Study 18724149 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1-site and 2-site)
Number of subjects: 113
Study 16180528 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP), 25 sessions
Number of subjects: 26
Study 16180528 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic short-term psychotherapy (PSTP)
Number of subjects: 26
Study 12824459 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg per day)
Number of subjects: 18882
Study 12824459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18882
Study 12824459 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18882
Study 10913814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg/day)
Number of subjects: 4937
Study 10913814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4937
Study 8886348 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation
Number of subjects: 0
Study 8886348 — intervention group
Group type: COMPARATOR
Intervention: Daily iron supplementation
Number of subjects: 0
Study 1905836 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune serum globulin (ISG) 2 ml i.m. at premedication and 2 ml i.m. on postoperative day 3
Number of subjects: 196
Study 1905836 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gammaglobulin or placebo)
Number of subjects: 196
Study 1905836 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune serum globulin (ISG)
Number of subjects: 196
Study 6351889 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (200 micrograms)
Number of subjects: 6
Study 6351889 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled reproterol (1 mg)
Number of subjects: 6
Study 31752559 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial sensors used by Rater A
Number of subjects: 20
Study 31752559 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial sensors used by Rater B
Number of subjects: 20
Study 31752559 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial sensors (inter-rater reliability)
Number of subjects: 20
Study 31752559 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial sensors (agreement measures)
Number of subjects: 20
Study 29407289 — intervention group
Group type: EXPERIMENTAL
Intervention: I-SOCIAL intervention combining individual and group sessions to address social challenges
Number of subjects: 0
Study 29407289 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26906110 — intervention group
Group type: EXPERIMENTAL
Intervention: high-resolution black-blood MRI (hr-bb-cMRI)
Number of subjects: 43
Study 1593145 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride (one ml) and buprenorphine 300 micrograms in combination (Group B)
Number of subjects: 60
Study 1593145 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine hydrochloride (one ml) (Group A)
Number of subjects: 60
Study 22723614 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal intervention (dietary counselling, controlled exercise, psychosocial support)
Number of subjects: 70
Study 22723614 — intervention group
Group type: COMPARATOR
Intervention: Control group (CGr)
Number of subjects: 70
Study 20350428 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics treatment group (Clostridium butyricum powder, 250 mg, twice daily up to discharge)
Number of subjects: 70
Study 20350428 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics treatment group
Number of subjects: 70
Study 18564698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibate (100 mg/kg single oral dose)
Number of subjects: 40
Study 16078334 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 40 microg
Number of subjects: 146
Study 16078334 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 10 mg
Number of subjects: 146
Study 12425125 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine, 1.5 mg/kg
Number of subjects: 74
Study 12425125 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium, 0.03 mg/kg
Number of subjects: 74
Study 10325273 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D endometrial ultrasound measurements (endometrial thickness and volume) on the day of oocyte retrieval
Number of subjects: 47
Study 8611046 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1049
Study 2011700 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily for 2 weeks
Number of subjects: 450
Study 2011700 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole once daily for 4 weeks
Number of subjects: 450
Study 2011700 — intervention group
Group type: COMPARATOR
Intervention: 300 mg ranitidine once daily for 2 weeks
Number of subjects: 450
Study 2011700 — intervention group
Group type: COMPARATOR
Intervention: 300 mg ranitidine once daily for 4 weeks
Number of subjects: 450
Study 6399407 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole (2-gram single dose)
Number of subjects: 33
Study 6399407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 30632104 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated standardized patients (SPs)
Number of subjects: 96
Study 30632104 — intervention group
Group type: COMPARATOR
Intervention: Standardized patients (SPs)
Number of subjects: 96
Study 30632104 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologists
Number of subjects: 96
Study 30632104 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care physicians (PCPs)
Number of subjects: 96
Study 30081103 — intervention group
Group type: EXPERIMENTAL
Intervention: Real air purifier
Number of subjects: 36
Study 30081103 — intervention group
Group type: COMPARATOR
Intervention: Sham air purifier
Number of subjects: 36
Study 26753986 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 90
Study 26753986 — intervention group
Group type: EXPERIMENTAL
Intervention: GMT plus metacognitive training (GMT + Meta)
Number of subjects: 90
Study 26753986 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined GMT groups
Number of subjects: 90
Study 26753986 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 24563385 — intervention group
Group type: EXPERIMENTAL
Intervention: Second DBS lead ON (double stimulation)
Number of subjects: 5
Study 24563385 — intervention group
Group type: COMPARATOR
Intervention: Vim DBS alone
Number of subjects: 5
Study 24563385 — intervention group
Group type: COMPARATOR
Intervention: Second lead ON (Vim OFF)
Number of subjects: 5
Study 23061078 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer EBUS‐TBNA simulation
Number of subjects: 12
Study 23061078 — intervention group
Group type: COMPARATOR
Intervention: Wet lab simulation
Number of subjects: 12
Study 19825916 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 36
Study 19825916 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% succinylated gelatin (GEL)
Number of subjects: 36
Study 19825916 — intervention group
Group type: COMPARATOR
Intervention: lactated Ringer's (RL) solution
Number of subjects: 36
Study 21305543 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate level of transference interpretations
Number of subjects: 0
Study 21305543 — intervention group
Group type: COMPARATOR
Intervention: No transference interpretation
Number of subjects: 0
Study 16040619 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 2599
Study 16040619 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate
Number of subjects: 2599
Study 16040619 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker dose
Number of subjects: 2599
Study 16040619 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HR and SBP
Number of subjects: 2599
Study 16040619 — intervention group
Group type: EXPERIMENTAL
Intervention: HR above median and SBP below median at 4 months
Number of subjects: 2599
Study 12898821 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal aortography with selective angiography
Number of subjects: 35
Study 9685764 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental hygienist-delivered intervention for smokeless tobacco users
Number of subjects: 75
Study 9685764 — intervention group
Group type: COMPARATOR
Intervention: Control group (cigarette smokers)
Number of subjects: 75
Study 7977730 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain triglycerides (LCT)
Number of subjects: 16
Study 7977730 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of long- and medium-chain triglycerides (MCT/LCT)
Number of subjects: 16
Study 7977730 — intervention group
Group type: EXPERIMENTAL
Intervention: LCT or MCT/LCT at 70% of nonprotein caloric intake
Number of subjects: 16
Study 2543094 — intervention group
Group type: EXPERIMENTAL
Intervention: gastrocepin (20 patients)
Number of subjects: 40
Study 2543094 — intervention group
Group type: EXPERIMENTAL
Intervention: dalargin (20 patients)
Number of subjects: 40
Study 2543094 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 40
Study 28863298 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive case management
Number of subjects: 914
Study 28863298 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 914
Study 28391116 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective working memory training (aWMT) for 20 days
Number of subjects: 30
Study 28391116 — intervention group
Group type: COMPARATOR
Intervention: Placebo training (feature match task) for 20 days
Number of subjects: 30
Study 26212489 — intervention group
Group type: EXPERIMENTAL
Intervention: E4/DRSP (5 mg or 10 mg E4/3 mg DRSP)
Number of subjects: 109
Study 26212489 — intervention group
Group type: EXPERIMENTAL
Intervention: E4/LNG (5 mg, 10 mg or 20 mg E4/150 μg LNG)
Number of subjects: 109
Study 26212489 — intervention group
Group type: COMPARATOR
Intervention: EE/DRSP (20 μg EE/3 mg DRSP)
Number of subjects: 109
Study 26212489 — intervention group
Group type: EXPERIMENTAL
Intervention: E4/DRSP and E4/LNG
Number of subjects: 109
Study 23435022 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 76
Study 19940484 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing
Number of subjects: 150
Study 19940484 — intervention group
Group type: COMPARATOR
Intervention: Non-gum-chewing (Control)
Number of subjects: 150
Study 17645506 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin 150 IU/kg three times weekly
Number of subjects: 74
Study 17645506 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 74
Study 17645506 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin
Number of subjects: 74
Study 17645506 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study 16832680 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost 1 ng/kg/min
Number of subjects: 45
Study 16832680 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost 2 ng/kg/min
Number of subjects: 45
Study 16832680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 12803265 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Def-3 (cuff deflation every 30 min for 3 hours)
Number of subjects: 20
Study 12803265 — intervention group
Group type: COMPARATOR
Intervention: Group Def-4 (cuff deflation every 30 min for 4 hours)
Number of subjects: 20
Study 11310081 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy during the examination
Number of subjects: 64
Study 11310081 — intervention group
Group type: COMPARATOR
Intervention: Usual procedural care (Control)
Number of subjects: 64
Study 11310081 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 64
Study 8707479 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracerebral applications of picotesla (pT) range electromagnetic fields (EMFs)
Number of subjects: 3
Study 8707479 — intervention group
Group type: COMPARATOR
Intervention: Placebo EMF treatment
Number of subjects: 3
Study 1731461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sematilide (0.15 to 1.5 mg/kg over 15 minutes)
Number of subjects: 14
Study 1731461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sematilide (high concentrations greater than or equal to 2 micrograms/ml)
Number of subjects: 14
Study 1731461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sematilide (plasma concentrations greater than or equal to 0.8 micrograms/ml)
Number of subjects: 14
Study 1731461 — intervention group
Group type: EXPERIMENTAL
Intervention: Sematilide
Number of subjects: 14
Study 6691639 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer reminders generated by 1490 rules
Number of subjects: 12467
Study 6691639 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 12467
Study 6691639 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group intentions to use a given action
Number of subjects: 12467